Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet needs.   We introduced a novel class of inhaled medicine and have an FDA approved medicine targeting PDE 3 and 4 enzymes. This novel approach could unlock the potential of targeting PDE3 and PDE4 across serious respiratory diseases. For more information, please visit www.veronapharma.com  

Contact	Visit Website

Return to Exhibit Hall

RESOURCES

Clinical Highlights

Product Summary

How to Prescribe